Yohimbine Enhances Protection of Berberine against LPS-Induced Mouse Lethality through Multiple Mechanisms

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Li, Hui ^a   Wang, Yiyang ^a   Zhang, Haoqing ^b   Jia, Baoyin ^a   Wang, Daan ^a   Li, Hongmei ^a   Lu, Daxiang ^a   Qi, Renbin ^a   Yan, Yuxia ^a   Wang, Huadong ^a  

^a MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

^b THE FIRST PEOPLE S HOSPITAL OF CHENZHOU   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BERBERINE; BETA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE TYK2; STAT1 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; YOHIMBINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; IMMUNOMODULATION; LETHALITY; LIVER INJURY; LIVER PROTECTION; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SEPSIS; SURVIVAL RATE; TREATMENT RESPONSE; UPREGULATION;

ANIMALS; BERBERINE; CELLS, CULTURED; DRUG SYNERGISM; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED BALB C; MYDRIATICS; SEPSIS; SIGNAL TRANSDUCTION; YOHIMBINE;

BACTERIA (MICROORGANISMS); MUS; NEGIBACTERIA; ZIZIPHUS MAURITIANA;

EID: 84871681193     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052863     Document Type: Article

References (32)

1. Anas AA, Wiersinga WJ, de Vos AF, van der Poll T, (2010) Recent insights into the pathogenesis of bacterial sepsis. Neth J Med 68: 147-152.
2. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL, (2007) Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med 35: 1244-1250.
3. Moore LJ, Moore FA, Todd SR, Jones SL, Turner KL, et al. (2010) Sepsis in general surgery: the 2005-2007 national surgical quality improvement program perspective. Arch Surg 145: 695-700.
4. Delsesto D, Opal SM, (2011) Future perspectives on regulating pro-and anti-inflammatory responses in sepsis. Contrib Microbiol 17: 137-156.
5. Marshall JC, (2010) Endotoxin in the pathogenesis of sepsis. Contrib Nephrol 167: 1-13.
6. Lu YC, Yeh WC, Ohashi PS, (2008) LPS/TLR4 signal transduction pathway. Cytokine 42: 145-151.
7. Fujihara M, Muroi M, Tanamoto K, Suzuki T, Azuma H, et al. (2003) Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex. Pharmacol Ther 100: 171-194.
8. Kamezaki K, Shimoda K, Numata A, Matsuda T, Nakayama K, et al. (2004) The role of Tyk2, Stat1 and Stat4 in LPS-induced endotoxin signals. Int Immunol 16: 1173-1179.
9. Rittirsch D, Flierl MA, Ward PA, (2008) Harmful molecular mechanisms in sepsis. Nat Rev Immunol 8: 776-787.
10. Li F, Wang HD, Lu DX, Wang YP, Qi RB, et al. (2006) Neutral sulfate berberine modulates cytokine secretion and increases survival in endotoxemic mice. Acta Pharmacol Sin 27: 1199-1205.
11. Kang BY, Chung SW, Cho D, Kim TS, (2002) Involvement of p38 mitogen-activated protein kinase in the induction of interleukin-12 p40 production in mouse macrophages by berberine, a benzodioxoloquinolizine alkaloid. Biochem Pharmacol 63: 1901-1910.
12. Zhang HQ, Wang HD, Lu DX, Qi RB, Wang YP, et al. (2008) Berberine inhibits cytosolic phospholipase A2 and protects against LPS-induced lung injury and lethality independent of the alpha2-adrenergic receptor in mice. Shock 29: 617-622.
13. Ponte CB, Alves EA, Sampaio RN, Urdapilleta AA, Kückelhaus Cdos S, et al. (2012) Miltefosine enhances phagocytosis but decreases nitric oxide production by peritoneal macrophages of C57BL/6 mice. Int Immunopharmacol 13: 114-119.
14. Miksa M, Das P, Zhou M, Wu R, Dong W, et al. (2009) Pivotal role of the alpha (2A)-adrenoceptor in producing inflammation and organ injury in a rat model of sepsis. PLoS One 4: e5504.
15. Wang YY, Li HM, Wang HD, Peng XM, Wang YP, et al. (2011) Pretreatment with berberine and yohimbine protects against LPS-induced myocardial dysfunction via inhibition of cardiac I-[kappa]B[alpha] phosphorylation and apoptosis in mice. Shock 35: 322-328.
16. Li HM, Wang YY, Wang HD, Cao WJ, Yu XH, et al. (2011) Berberine protects against lipopolysaccharide-induced intestinal injury in mice via alpha 2 adrenoceptor-independent mechanisms. Acta Pharmacol Sin 32: 1364-1372.
17. Karima R, Matsumoto S, Higashi H, Matsushima K, (1999) The molecular pathogenesis of endotoxic shock and organ failure. Mol Med Today 5: 123-132.
18. Hochholzer P, Lipford GB, Wagner H, Pfeffer K, Heeg K, (2000) Role of interleukin-18 (IL-18) during lethal shock: decreased lipopolysaccharide sensitivity but normal superantigen reaction in IL-18-deficient mice. Infect Immun 68: 3502-3508.
19. Ando H, Takamura T, Ota T, Nagai Y, Kobayashi K, (2000) Cerivastatin improves survival of mice with lipopolysaccharide-induced sepsis. J Pharmacol Exp Ther 294: 1043-1046.
20. Tateda K, Matsumoto T, Miyazaki S, Yamaguchi K, (1996) Lipopolysaccharide-induced lethality and cytokine production in aged mice. Infect Immun 64: 769-774.
21. Rothe J, Lesslauer W, Lötscher H, Lang Y, Koebel P, et al. (1993) Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364: 798-802.
22. Fantuzzi G, Zheng H, Faggioni R, Benigni F, Ghezzi P, et al. (1996) Effect of endotoxin in IL-1 beta-deficient mice. J Immunol 157: 291-296.
23. Laubach VE, Shesely EG, Smithies O, Sherman PA, (1995) Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc Natl Acad Sci USA 92: 10688-10692.
24. Guarda G, So A, (2010) Regulation of inflammasome activity. Immunology 130: 329-336.
25. Negishi M, Izumi Y, Aleemuzzaman S, Inaba N, Hayakawa S, (2011) Lipopolysaccharide (LPS)-induced Interferon (IFN)-gamma production by decidual mononuclear cells (DMNC) is interleukin (IL)-2 and IL-12 dependent. Am J Reprod Immunol 65: 20-27.
26. Howard M, Muchamuel T, Andrade S, Menon S, (1993) Interleukin-10 protects mice from lethal endotoxemia. J Exp Med 177: 1205-1208.
27. Standiford TJ, Strieter RM, Lukacs NW, Kunkel SL, (1995) Neutralization of IL-10 increases lethality in endotoxemia. Cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor. J Immunol 155: 2222-2229.
28. Goldsmith M, Avni D, Ernst O, Glucksam Y, Levy-Rimler G, et al. (2009) Synergistic IL-10 induction by LPS and the ceramide-1-phosphate analog PCERA-1 is mediated by the cAMP and p38 MAP kinase pathways. Mol Immunol 46: 1979-1987.
29. Toshchakov V, Jones BW, Perera PY, Thomas K, Cody MJ, et al. (2002) TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages. Nat Immunol 3: 392-398.
30. Sakaguchi S, Negishi H, Asagiri M, Nakajima C, Mizutani T, et al. (2003) Essential role of IRF-3 in lipopolysaccharide-induced interferon-β gene expression and endotoxin shock. Biochem Biophys Res Commun 306, 860-866.
31. Karaghiosoff M, Steinborn R, Kovarik P, Kriegshäuser G, Baccarini M, et al. (2003) Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock. Nat Immunol 4: 471-477.
32. O'Sullivan JB, Ryan KM, Harkin A, Connor TJ, (2010) Noradrenaline reuptake inhibitors inhibit expression of chemokines IP-10 and RANTES and cell adhesion molecules VCAM-1 and ICAM-1 in the CNS following a systemic inflammatory challenge. J Neuroimmunol 220: 34-42.